Annual report pursuant to Section 13 and 15(d)

NET LOSS PER SHARE - Outstanding potentially dilutive common shares (Details)

v3.24.1
NET LOSS PER SHARE - Outstanding potentially dilutive common shares (Details) - shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive common shares equivalents excluded from computation of diluted net loss per share for periods presented because including them would have been antidilutive 15,136,252 4,084,375
Pre- funded warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Number of warrants to purchase common shares 594,725  
Employee Stock Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive common shares equivalents excluded from computation of diluted net loss per share for periods presented because including them would have been antidilutive 967,262 1,043,025
Warrants.    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive common shares equivalents excluded from computation of diluted net loss per share for periods presented because including them would have been antidilutive 13,001,262 1,873,622
Series 1 Convertible Preferred Share Member    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive common shares equivalents excluded from computation of diluted net loss per share for periods presented because including them would have been antidilutive   1,166,667
Series 2 Convertible Preferred Share Member    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive common shares equivalents excluded from computation of diluted net loss per share for periods presented because including them would have been antidilutive 1,166,667  
Deferred share units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive common shares equivalents excluded from computation of diluted net loss per share for periods presented because including them would have been antidilutive 1,061 1,061